Pacer Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14M | Sell |
645,132
-209,235
| -24% | -$4.54M | 0.03% | 388 |
|
|
2025
Q1 | $20.7M | Sell |
854,367
-2,101,141
| -71% | -$51M | 0.05% | 291 |
|
|
2024
Q4 | $61.7M | Buy |
2,955,508
+151,495
| +5% | +$3.16M | 0.13% | 170 |
|
|
2024
Q3 | $55.7M | Sell |
2,804,013
-163,562
| -6% | -$3.25M | 0.12% | 191 |
|
|
2024
Q2 | $46M | Buy |
2,967,575
+2,965,310
| +130,919% | +$45.9M | 0.1% | 209 |
|
|
2024
Q1 | $36.1K | Buy |
+2,265
| New | +$36.1K | ﹤0.01% | 3302 |
|
|
2023
Q2 | – | Sell |
-513,734
| Closed | -$8.52M | – | 3534 |
|
|
2023
Q1 | $8.52M | Buy |
+513,734
| New | +$8.52M | 0.04% | 451 |
|
|
2021
Q2 | – | Sell |
-10,206
| Closed | -$47K | – | 1441 |
|
|
2021
Q1 | $47K | Buy |
10,206
+1,598
| +19% | +$7.36K | ﹤0.01% | 1442 |
|
|
2020
Q4 | $29K | Sell |
8,608
-737
| -8% | -$2.48K | ﹤0.01% | 1463 |
|
|
2020
Q3 | $28K | Buy |
+9,345
| New | +$28K | ﹤0.01% | 1340 |
|